(102 days)
Not Found
No
The device description and intended use clearly describe a manual aneroid sphygmomanometer, which relies on mechanical components and manual detection of Korotkoff sounds, with no mention of AI or ML.
No.
The device is an aneroid sphygmomanometer used for measuring blood pressure, which is a diagnostic rather than a therapeutic function.
Yes
Explanation: The device measures systolic and diastolic blood pressure, which provides information about a patient's health status and can be used to identify conditions like hypertension.
No
The device description explicitly lists hardware components such as a manometer, cuff bladder, inflation bulb, and optional stethoscopes.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This testing is done outside of the body (in vitro).
- Device Function: The described device, an aneroid sphygmomanometer, measures blood pressure by applying pressure to the arm and listening for sounds (Korotkoff sounds). This is a physical measurement taken on the patient's body, not a test performed on a sample taken from the body.
- Intended Use: The intended use clearly states it's for measuring systolic and diastolic pressure on children or adults by being manually attached to a patient. This aligns with a physical measurement device, not an IVD.
The description and intended use clearly indicate that this is a device for in vivo measurement (measurement within or on the living body), not in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
Aneroid Sphygmomanometer is intended to be used by medical professionals or in the home for the measurement of systolic and diastolic pressure on children or adults. The device is intended to be manually attached to a patient and manually inflated along with a manual method for detecting Korotkoff sounds.
Product codes
DXO, LDE
Device Description
The proposed device is composed of manometer, cuff bladder, inflation bulb and optioned stethoscopes. It is available in four models, MC-20A, MC-30 and MC-50, which are different in cuff material, cuff bladder material and stethoscope option. The aneroid sphygmomanometer should be used in conjunction with a stethoscope. For model MC-50, there are three types of stethoscope for option: Single Head, Dual Head and Sprague Rappaport stethoscope, while the other models of the proposed device do not have stethoscope in configuration. There are also six sizes of cuff for each model device in order to fit varies arm circumference of user. The proposed device is Over-The-Counter use, non-sterile, reusable device.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Upper Arm (leg for child)
Indicated Patient Age Range
children or adults. infants, children, young adults and adults
Intended User / Care Setting
medical professionals or in the home. Home, Hospital, healthcare facility, ambulance etc.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:
- A ISO 81060-1:2007 Non-invasive sphygmomanometers - Part 1: Requirements and test methods for non-automated measurement type.
-
ISO 10993-5:2009 Biological Evaluation of Medical Devices-Part 5: Tests for in Vitro Cytotoxicity;
- A ISO 10993-10:2010 Biological Evaluation of Medical Devices-Part 10: Tests for Irritation and Skin Sensitization;
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
No clinical study is included in this submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Accuracy: Pressure: +/- 3 mmHg of reading.
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1120 Blood pressure cuff.
(a)
Identification. A blood pressure cuff is a device that has an inflatable bladder in an inelastic sleeve (cuff) with a mechanism for inflating and deflating the bladder. The cuff is used in conjunction with another device to determine a subject's blood pressure.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo for the U.S. Food & Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the text on the right. The symbol is a stylized representation of a caduceus, a traditional symbol of medicine, with intertwined snakes and wings. To the right of the symbol is the text "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue, with "FDA" in a larger font size than the rest of the text.
March 23, 2021
Wuxi Exanovo Medical Instrument Co., Ltd. % Diana Hong General Manager Mid-Link Consulting Co., Ltd P.O. Box 120-119 Shanghai, Shanghai 200120 China
Re: K203620
Trade/Device Name: Aneroid Sphygmomanometer Regulation Number: 21 CFR 870.1120 Regulation Name: Blood pressure cuff Regulatory Class: Class II Product Code: DXO, LDE Dated: January 22, 2021 Received: January 22, 2021
Dear Diana Hong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see
https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for LT Stephen Browning Assistant Director DHT2A: Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K203620
Device Name
Aneroid Sphygmomanometer
Indications for Use (Describe)
Aneroid Sphygmomanometer is intended to be used by medical professionals or in the home for the measurement of systolic and diastolic pressure on children or adults. The device is intended to be manually attached to a patient and manually inflated along with a manual method for detecting Korotkoff sounds.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
× Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.
PSC Publishing Services (301) 443-6740 EF
3
Tab #6 510(k) Summary
This 510(k) Summary is being submitted in accordance with requirements of Title 21, CFR Section 807.92.
The assigned 510(k) Number: K203620
-
- Date of Preparation: 12/15/2020
-
- Sponsor Identification
Wuxi Exanovo Medical Instrument Co., Ltd.
No.42, Xixin Road, Zhangjing, Xibei Town, Wuxi City, 214194, China
Establishment Registration Number: Not assigned
Contact Person: Xiao Huang Position: General Manager Tel: +86-0510-83791431 Fax: +86-0510-83796580 Email: wuximedical(@vip.163.com
-
- Designated Submission Correspondent
Ms. Diana Hong (Primary Contact Person) Ms. Jing Cheng (Alternative Contact Person)
- Designated Submission Correspondent
Mid-Link Consulting Co., Ltd
P.O. Box 120-119, Shanghai, 200120, China
Tel: +86-21-22815850 Fax: 360-925-3199 Email: info@mid-link.net
4
4. Identification of Proposed Device
Trade Name: Aneroid Sphygmomanometer Classification Name: Blood pressure cuff
Regulatory Information Classification Name: Blood pressure cuff Classification: II; Product Code: DXQ Regulation Number: 21CFR 870.1120 Review Panel: Cardiovascular
Regulatory Information
Classification Name: Stethoscope, manual Classification: II; Product Code: LDE Regulation Number: 21 CFR 870.1875 Review Panel: Cardiovascular
Indications for Use
Aneroid Sphygmomanometer is intended to be used by medical professionals or in the home for the measurement of systolic and diastolic pressure on children or adults. The device is intended to be manually attached to a patient and manually inflated along with a manual method for detecting Korotkoff sounds.
Device Description
The proposed device is composed of manometer, cuff bladder, inflation bulb and optioned stethoscopes. It is available in four models, MC-20A, MC-30 and MC-50, which are different in cuff material, cuff bladder material and stethoscope option. The aneroid sphygmomanometer should be used in conjunction with a stethoscope. For model MC-50, there are three types of stethoscope for option: Single Head, Dual Head and Sprague Rappaport stethoscope, while the other models of the proposed device do not have stethoscope in configuration. There are also six sizes of cuff for each model device in order to fit varies arm circumference of user. The proposed device is Over-The-Counter use, non-sterile, reusable device.
- న్. Identification of Predicate Device
510(k) Number: K190902
Product Name: RH non-Automated Blood Pressure Meter, MODEL Max02 and RH non-Automated Blood Pressure Meter with Stethoscope, MODEL Max0201, Max0202, Max0203
-
- Non-Clinical Test Conclusion
Non clinical tests were conducted to verify that the proposed device met all design specifications
- Non-Clinical Test Conclusion
5
as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:
- A ISO 81060-1:2007 Non-invasive sphygmomanometers - Part 1: Requirements and test methods for non-automated measurement type.
-
ISO 10993-5:2009 Biological Evaluation of Medical Devices-Part 5: Tests for in Vitro Cytotoxicity;
- A ISO 10993-10:2010 Biological Evaluation of Medical Devices-Part 10: Tests for Irritation and Skin Sensitization;
-
- Clinical Test Conclusion
No clinical study is included in this submission.
- Substantially Equivalent (SE) Comparison 8.
ITEM | Proposed Device | Predicate Device | Remark |
---|---|---|---|
Product Code | DXQ, LDE | DXQ, LDE | SE |
Regulation No. | 21 CFR 870.1120 | 21 CFR 870.1120 | SE |
Class | II | II | SE |
Indication for Use | Aneroid Sphygmomanometer is intended to be used by medical professionals or in the home for the measurement of systolic and diastolic pressure on children or adults. The device is intended to be manually attached to a patient and manually inflated along with a manual method for detecting Korotkoff sounds. | RH non-Automated Blood Pressure Meter is intended to be used by medical professionals or in the home for the measurement of systolic and diastolic pressure on children or adults. The device is intended to be manually attached to a patient and manually inflated along with a manual method for detecting Korotkoff sounds. | SE |
Over-The Counter Use | Yes | Yes | SE |
Where used | Home, Hospital, healthcare facility, ambulance etc. | Home, Hospital, healthcare facility, ambulance etc. | SE |
Target population | infants, children, young adults and adults | infants, children, young adults and adults | SE |
Anatomical sites | Upper Arm (leg for child) | Upper Arm (leg for child) | SE |
Measurement Method | Auscultatory Korotkoff sounds Method | Auscultatory Korotkoff sounds Method | SE |
Inflation | Manual by inflation bulb | Manual by inflation bulb | SE |
Deflation | Manual deflation via valve | Manual deflation via valve | SE |
Display | Aneroid Manometer | Aneroid Manometer | SE |
The monitor | |||
scale | From 0 to 300 mmHg with a | ||
minimum interval of 2 mmHg. | From 0 to 300 mmHg with a | ||
minimum interval of 2 mmHg. | SE | ||
Design of blood | |||
pressure meter | The device comprises tubing | ||
attached to a soft inelastic cuff with | |||
an integrated inflatable bladder that | |||
is wrapped around the patient's limb | |||
and secured by hook and loop | |||
closure. | The device comprises tubing | ||
attached to a soft inelastic cuff with | |||
an integrated inflatable bladder that | |||
is wrapped around the patient's limb | |||
and secured by hook and loop | |||
closure. | SE | ||
Design of | |||
Stethoscope | Three types option: | ||
Single head | |||
Dual head | |||
Sprague Rappaport | Three types option: | ||
Single head | |||
Dual head | |||
Sprague Rappaport | SE | ||
Materials | The manometer: aluminum and | ||
stainless steel materials. | |||
The tubing, inflation bulb: PVC or | |||
nature latex. | |||
Cuff: Nylon cloth or cotton cloth for | |||
outside layer. | |||
Cuff bladder: PVC or nature latex | The manometer: aluminum and | ||
stainless steel materials. | |||
The tubing, inflation bulb: PVC or | |||
nature latex. | |||
Cuff: Nylon cloth or cotton cloth for | |||
outside layer. | |||
Cuff bladder: PVC or nature latex | SE | ||
Accuracy | Pressure: +/- 3 mmHg of reading. | Pressure: +/- 3 mmHg of reading. | SE |
Compatibility | |||
with environment | It can be used from 50°F to 104°F | ||
(10°C to 40°C ) and | |||
15% ~ 85%RH humidity. | It can be used from 50°F to 104°F | ||
(10°C to 40°C ) and | |||
15%~85%RH humidity. | SE | ||
Cuff Sizes | 21" × 5.7"(540mm*145mm) | ||
26" × 6.9" (660mm*175mm) | |||
30.7" × 8.67" (780mm*220mm) | |||
14.96" × 4.33" (380mm*110mm) | |||
11.81" ×2.76" (300mm*70mm) | |||
9.84" × 2.16"(250mm*55mm) | 20" × 5.5" (510mm*140mm) | ||
21.7" × 6.3" (550mm*160mm) | |||
24.4" × 6.9" (620mm*175mm) | |||
28.3" × 8.3" (720mm*210mm) | |||
13.4" × 4.15" (340mm*105mm) | |||
10.2" x 3" (260mm*75mm) | Analysis 1 | ||
Cuff | |||
Circumference | Fits arm circumferences 8.7" to | ||
17.3" (220mm to 440 mm), The | |||
standard cuff should be available for | |||
use in measuring a child's leg blood | |||
pressure and for children with larger | |||
arms. | Fits arm circumferences 8.7" to | ||
17.3" (220mm to 440 mm), The | |||
standard cuff should be available for | |||
use in measuring a child's leg blood | |||
pressure and for children with larger | |||
arms. | SE | ||
Cuff bladder Size | 8.7"×4.7" (220mm*120mm) | ||
11.8"×5.9" (300mm*150mm) | |||
14.76" × 7.28"(375mm*185mm) | |||
6.9"×3.3"(175mm*85mm) | |||
3.15" x 1.57"(80mm*40mm) | |||
3.54" × 0.98"(90mm*25mm) | 8.7" x 4.7" (220mm*120mm) | ||
11.8" x 5.9"(300mm*150mm) | |||
13.4" x 6.7" (340mm*170mm) | |||
6.9" x 3.3"(175mm*85mm) | |||
7.5" x 2"(190mm*50mm) | Analysis 2 |
Table 1 Comparison of Technology Characteristics
6
7
Cuff Color | Black | Blue, Pink, Black | Analysis 3 |
---|---|---|---|
Contents (with accessories) | Aneroid gauge, Arm Cuff, Inflation Bulb, Vinyl storage pouch and Instruction Manual, Stethoscope (option) | Aneroid gauge, Arm Cuff, Inflation Bulb, Vinyl storage pouch and Instruction Manual, Stethoscope (option) | SE |
Biocompatibility | biocompatible as requirement of ISO 10993-1, ISO 10993-5, ISO 10993-10 | biocompatible as requirement of ISO 10993-1, ISO 10993-5, ISO 10993-10 | SE |
Performance | compatible as requirement of ISO 81060-1 | compatible as requirement of ISO 81060-1 | SE |
Analysis 1 - Cuff Sizes
The cuff sizes of proposed device are different from predicate device. However, the cuff size of proposed device is similar to the predicate device and the Cuff Circumference of the two devices is the same. The Velcro on cuff is designed to fit varies arm circumference. This difference doesn't raise new problems on the safety and effectiveness of the proposed device. Therefore, this difference does not affect the substantially equivalence between the proposed device and predicate device.
Analysis 2 – Cuff bladder Size
The cuff bladder size of the proposed device is partly different from predicate device. However, the cuff bladder size of proposed device is similar to the predicate device. It could fit varies requirements of users. This difference doesn't raise new problems on the safety and effectiveness of the proposed device. Therefore, this difference does not affect the substantially equivalence between the proposed device and predicate device.
Analysis 3 – Cuff Color
The cuff color of the proposed device is different from the predicate device. However, the biocompatibility of the cuff of proposed device had been tested and the test results show no adverse effect of the material. Therefore, this difference does not affect the substantially equivalence between the proposed device and predicate device.
Equivalent (SE) Conclusion 9.
Based on the comparison and analysis above, the proposed device are determined to be Substantially Equivalent (SE) to the predicate device.